Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

Eileen Dareng(University of Cambridge), Simon G. Coetzee(Cedars-Sinai Medical Center), Jonathan P. Tyrer(University of Cambridge), Pei-Chen Peng(Cedars-Sinai Medical Center), Will Rosenow(University of Virginia), Stephanie Chen(Cedars-Sinai Medical Center), Brian Davis(Cedars-Sinai Medical Center), Felipe Segato Dezem(Cedars-Sinai Medical Center), Ji-Heui Seo(Dana-Farber Cancer Institute), Robbin Nameki(Cedars-Sinai Medical Center), Alberto Luiz P. Reyes(Cedars-Sinai Medical Center), Katja K.H. Aben(Radboud University Nijmegen), Hoda Anton‐Culver(University of California, Irvine), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Gerasimos Aravantinos(Hospital Agioi Anargyroi), Elisa V. Bandera(Rutgers, The State University of New Jersey), Laura E. Beane Freeman(National Institutes of Health), Matthias W. Beckmann(Universitätsklinikum Erlangen), Alicia Beeghly‐Fadiel(Vanderbilt University), Javier Benı́tez(Instituto de Salud Carlos III), Marcus Q. Bernardini(University Health Network), Line Bjørge(Haukeland University Hospital), Amanda Black(National Cancer Institute), Natalia Bogdanova(Medizinische Hochschule Hannover), Kelly L. Bolton(Washington University in St. Louis), James D. Brenton(University of Cambridge), Agnieszka Budziłowska, Ralf Bützow(University of Helsinki), Hui Cai(Vanderbilt University), Ian Campbell(The University of Melbourne), Rikki Cannioto(Roswell Park Comprehensive Cancer Center), Jenny Chang‐Claude(Universität Hamburg), Stephen J. Chanock(National Institutes of Health), Kexin Chen(Tianjin Medical University Cancer Institute and Hospital), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Yoke-Eng Chiew(Westmead Hospital), Linda S. Cook(Colorado School of Public Health), Anna DeFazio(The University of Sydney), Joe Dennis(University of Cambridge), Jennifer A. Doherty(University of Utah), Thilo Dörk(Medizinische Hochschule Hannover), Andreas du Bois(Helios Dr. Horst Schmidt Kliniken Wiesbaden), Matthias Dürst(Jena University Hospital), Diana M. Eccles(University of Southampton), Gabrielle Ene(University Health Network), Peter A. Fasching(Universitätsklinikum Erlangen), James M. Flanagan(Ovarian Cancer Action), Renée T. Fortner(German Cancer Research Center), Florentia Fostira(National Centre of Scientific Research "Demokritos"), Aleksandra Gentry‐Maharaj(MRC Clinical Trials Unit at UCL), Graham G. Giles(The University of Melbourne), Marc T. Goodman(Cedars-Sinai Medical Center), Jacek Gronwald(International Hereditary Cancer Center), Christopher A. Haiman(University of Southern California), Niclas Håkansson(Karolinska Institutet), Florian Heitz(Helios Dr. Horst Schmidt Kliniken Wiesbaden), Michelle A.T. Hildebrandt(The University of Texas MD Anderson Cancer Center), Estrid Høgdall(University of Copenhagen), Claus Høgdall(University of Copenhagen), Ruea‐Yea Huang(Roswell Park Comprehensive Cancer Center), Allan Jensen(Danish Cancer Society), Michael E. Jones(Cedars-Sinai Medical Center), Daehee Kang(Seoul National University), Beth Y. Karlan(University of California, Los Angeles), Anthony N. Karnezis(University of California Davis Medical Center), Linda E. Kelemen(Medical University of South Carolina), Catherine J. Kennedy(The University of Sydney), Э. К. Хуснутдинова(Bashkir State University), Lambertus A. Kiemeney(Radboud University Nijmegen), Susanne K. Kjær(University of Copenhagen), Jolanta Kupryjańczyk, Marilyne Labrie(Université de Sherbrooke), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Melissa C. Larson(Mayo Clinic in Florida), Nhu D. Le, Jenny Lester(University of California, Los Angeles), Lian Li(Tianjin Medical University Cancer Institute and Hospital), Jan Lubiński(International Hereditary Cancer Center), Michael Lush(University of Cambridge), Jeffrey R. Marks(Duke University Hospital), Keitaro Matsuo(Aichi Cancer Center), Taymaa May(University Health Network), John R. McLaughlin(Lunenfeld-Tanenbaum Research Institute), Iain A. McNeish(Ovarian Cancer Action), Usha Menon(MRC Clinical Trials Unit at UCL), Stacey A. Missmer(Brigham and Women's Hospital), Francesmary Modugno(University of Pittsburgh), Melissa Moffitt(Roswell Park Comprehensive Cancer Center), Álvaro N.A. Monteiro(Moffitt Cancer Center), Kirsten B. Moysich(Roswell Park Comprehensive Cancer Center), Steven A. Narod(University of Toronto), Tú Nguyen‐Dumont(The University of Melbourne), Kunle Odunsi(University of Chicago), Håkan Olsson(Lund University), N. Charlotte Onland‐Moret(University Medical Center Utrecht), Sue K. Park(Seoul National University), Tanja Pejović(Oregon Health & Science University), Jennifer B. Permuth(Moffitt Cancer Center), Anna Piskorz(University of Cambridge), Darya Prokofyeva(Bashkir State University), Marjorie J. Riggan(Duke University Hospital), Harvey A. Risch(Yale University), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Mary Anne Rossing(University of Washington), Dale P. Sandler(National Institute of Environmental Health Sciences), V. Wendy Setiawan(University of Southern California), Kang Shan(Hebei Medical University), Honglin Song(University of Cambridge), Melissa C. Southey(The University of Melbourne), Helen Steed(Alberta Health Services), Rebecca Sutphen(University of South Florida), Anthony J. Swerdlow(Institute of Cancer Research), Soo‐Hwang Teo(University of Malaya), Kathryn L. Terry(Brigham and Women's Hospital), Pamela J. Thompson(Cedars-Sinai Medical Center), Liv Cecilie Vestrheim Thomsen(Haukeland University Hospital), Linda Titus(University of Southern Maine), Britton Trabert(National Cancer Institute), Ruth C. Travis(University of Oxford), Shelley S. Tworoger(Moffitt Cancer Center), Ellen Valen(Haukeland University Hospital), Els Van Nieuwenhuysen, Digna Velez Edwards(Vanderbilt University Medical Center), Robert A. Vierkant(Mayo Clinic in Florida), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Clarice R. Weinberg(National Institute of Environmental Health Sciences), R Weise(University of Hawaiʻi at Mānoa), Nicolas Wentzensen(National Cancer Institute), Emily White(University of Washington), Stacey J. Winham(Mayo Clinic in Florida), Alicja Wolk(Uppsala University), Yin Ling Woo(University Malaya Medical Centre), Anna H. Wu(University of Southern California), Yan Li(Hebei Medical University), Drakoulis Yannoukakos(National Centre of Scientific Research "Demokritos"), Nur Zeinomar(Rutgers, The State University of New Jersey), Wei Zheng(Vanderbilt University), Argyrios Ziogas(University of California, Irvine), Andrew Berchuck(Duke University Hospital), Ellen L. Goode(Mayo Clinic in Florida), David G. Huntsman(BC Cancer Agency), Celeste Leigh Pearce(University of Southern California), Susan J. Ramus(Cancer Institute of New South Wales), Thomas A. Sellers(ABS Consulting (United States)), Matthew L. Freedman(Dana-Farber Cancer Institute), Kate Lawrenson(Cedars-Sinai Medical Center), Joellen M. Schildkraut(Emory University), Dennis J. Hazelett(Cedars-Sinai Medical Center), Jasmine Plummer(Cedars-Sinai Medical Center), Siddhartha Kar(University of Bristol), Michelle R. Jones(Cedars-Sinai Medical Center), Paul D.P. Pharoah(University of Cambridge), Simon A. Gayther(Cedars-Sinai Medical Center)
The American Journal of Human Genetics
May 8, 2024
Cited by 25Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis